Search Results 1111-1120 of 5034 for Tapeworm
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) · Overview · Participation eligibility.
Dr. Lisa Rimsza is a pathologist, director of the Molecular Diagnostics Arizona Laboratory and researcher with the Mayo Clinic Comprehensive Cancer Center. Her ...
The goal of this study is to correlate protein content in vestibular schwannomas and cerebrospinal fluid to patient outcomes, imaging findings, and other ...
PHOENIX — Mayo Clinic announces a groundbreaking achievement in organ transplantation, offering hope to thousands who have lost their ability to speak, swallow ...
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients with Gastrointestinal Stromal Tumour After Progression with ...
Early detection improves treatment outcomes for endometrial and ovarian cancers, yet far too often women are diagnosed in advanced stages of these diseases.
The purpose of this study is to investigate the effectiveness and safety of REC-2282 in patients with progressive NF2 mutated meningiomas who have either NF2 ...
Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Highlights of ...
Timothy D. Lyon, M.D., urologic oncologist at Mayo Clinic Comprehensive Cancer Center, answers questions about advancements in bladder cancer care and ...
Growing up as the child of a voice instructor, Emily Hardy developed a lifelong interest in singing. But the third-year student at Mayo Clinic Alix[...] ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.